SCHEMBL5693103

SCHEMBL5693103

CC(C)(C)c1cc(CC[Si](C)(C)C)cc(C(C)(C)C)c1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.52
GAA P10253 5/20 0.52
TSHR P16473 4/20 0.52
LMNA P02545 3/20 0.52
KMT2A Q03164 4/20 0.50
MAPK1 P28482 3/20 0.50
MAPT P10636 3/20 0.50
MEN1 O00255 3/20 0.50
KDM4E B2RXH2 3/20 0.50
GSR P00390 2/20 0.50
CYP1A2 P05177 2/20 0.50
CYP3A4 P08684 2/20 0.50
BLM P54132 2/20 0.50
ATM Q13315 2/20 0.50
HIF1A Q16665 2/20 0.50
NPSR1 Q6W5P4 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
HPGD P15428 2/20 0.50
HTT P42858 1/20 0.50
GMNN O75496 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9193491 0.89 ALDH1A1 (0.52) ALDH1A1GAATSHRLMNAKMT2A
SCHEMBL284696 0.83 ALDH1A1 (0.63) ALDH1A1GAATSHRLMNAKMT2A
SCHEMBL5693112 0.83 ALDH1A1 (0.50) ALDH1A1GAATSHRLMNAKMT2A
SCHEMBL5609679 0.82 ALDH1A1 (0.60) ALDH1A1GAATSHRLMNAKMT2A
SCHEMBL9190234 0.81 ALDH1A1 (0.51) ALDH1A1GAATSHRLMNAKMT2A
SCHEMBL7520072 0.80 ALDH1A1 (0.48) ALDH1A1GAATSHRLMNAMAPK1
SCHEMBL8751536 0.79 ALDH1A1 (0.59) ALDH1A1GAATSHRLMNAKMT2A
SCHEMBL283499 0.79 ALDH1A1 (0.59) ALDH1A1GAATSHRLMNAKMT2A
SCHEMBL7530152 0.79 GAA (0.48) ALDH1A1GAATSHRLMNAKMT2A
SCHEMBL5692085 0.79 GAA (0.48) ALDH1A1GAATSHRLMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1468692-B1 Use of 2,6-di-alkyl-4-silyl-phenols for treating xanthoma MERRELL PHARMA INC (US) 2006-04-26 EP disclosed
EP-0732928-B1 METHOD OF LOWERING SERUM CHOLESTEROL LEVELS WITH 2,6-DI-ALKYL-4-SILYL-PHENOLS MERRELL PHARMA INC (US) 2004-12-22 EP disclosed
EP-1468693-A2 Use of 2,6-di -alkyl-4-silyl-phenols for treating diabetes mellitus MERRELL PHARMACEUTICALS INC. (US) 2004-10-20 EP disclosed
EP-1468692-A2 Use of 2,6-di-alkyl-4-silyl-phenols for treating xanthoma MERRELL PHARMACEUTICALS INC. (US) 2004-10-20 EP disclosed
US-5795876-A ANTIINFLAMMATORY AGENTS HOECHST MARION ROUSSSEL, INC. (US) 1998-08-18 US disclosed
US-5532400-A 2,6-di-alkyl-4-silyl-phenols as antiatheroscelerotic agents MERRELL PHARMACEUTICALS INC. (US) 1996-07-02 US disclosed
EP-0464852-B1 Novel 2,6-di-alkyl-4-silyl-phenols as antiatherosclerotic agents and as antioxidants MERRELL DOW PHARMA (US) 1996-03-20 EP disclosed
US-5155250-A 2,6-DI-ALKYL-4-SILYL-PHENOLS AS ANTIATHEROSCEROTIC AGENTS MERRELL DOW PHARMACEUTICALS INC. (US) 1992-10-13 US disclosed
EP-0464852-A1 Novel 2,6-di-alkyl-4-silyl-phenols as antiatherosclerotic agents and as antioxidants MERRELL PHARMACEUTICALS INC. (US) 1992-01-08 EP disclosed